NIH researchers identified new genetic disorder that affects brain, craniofacial skeleton
On Jan. 21, 2021, researchers at the NIH announced they had discovered a new genetic disorder characterized by…
-
-
Lilly’s neutralizing antibody bamlanivimab (LY-CoV555) prevented COVID-19 at nursing homes in the BLAZE-2 trial
On Jan. 21, 2021, Eli Lilly announced that bamlanivimab (LY-CoV555) significantly reduced the risk of contracting symptomatic COVID-19…
-
Developmental origins of eczema and psoriasis discovered
On Jan. 21, 2021, scientists at the Wellcome Sanger Institute announced they had created a highly detailed map…
-
XBiotech candidate True Humanﾙ COVID-19 therapy found to target highly infectious emerging strain
On Jan. 21, 2021, XBiotech announced that its COVID-19 candidate True Humanﾙ antibody therapy may also be used…
-
Patients in cancer remission at high risk for severe COVID-19 illness
On Jan. 21, 2021, Penn Medicine reported that patients with inactive cancer and not currently undergoing treatments also…
-
Moderna announced first participant dosed in phase 1/2 study of COVID-19 vaccine in Japan led by Takeda
On Jan. 21, 2021, Moderna announced that the first participant has been dosed in the Phase 1/2 study…
-
Janssen announced FDA approval of CABENUVA, the first long-acting HIV treatment regimen
On Jan. 21, 2021, Janssen Pharmaceutical announced the FDA had approved CABENUVA (consisting of Janssenﾒs rilpivirine and ViiV…
-
The US Department of Defense recommended adults 75 and older should seek COVID-19 vaccine
On Jan. 21, 2021, the U.S. Department of Defense (DOD) recommended that adults ages 75 and older should…
-
VBI Vaccines announced progress of Coronavirus vaccine program
On Jan. 21, 2021, VBI Vaccines announced that it expected to initiate the first Phase 1/2 clinical study…
-
Mesa Biotech received 510(k) clearance and CLIA waiver for Its Accula Strep A Molecular Point of Care Test
On Jan. 19, 2021, Mesa Biotech announced it had received 510(k) clearance and Clinical Laboratory Improvements Amendments (CLIA)…
-
Heat Biologics commenced manufacturing process for ZVX-60
On Jan. 19, 2021, Heat Biologics announced it had transferred its gp96-based COVID-19 vaccine cell line (“ZVX-60”) to…
-
Cue’s Molecular, point-of-care COVID-19 tests available under HHS and DoD pilot program
On Jan. 19, 2021, Cue Health announced that its molecular, point-of-care COVID-19 Tests were being distributed to five…
-
ImmunityBio announced phase I trial of COVID-19 vaccine candidate in South Africa as new variants spread
On Jan. 19, 2021, ImmunityBio announced it had received authorization from the South Africa Health Products Regulatory Authority…
-
ImmunityBio simulations revealed why spreading South Africa strain of SARS-CoV-2 may escape existing immunity
On Jan. 19, 2021, ImmunityBio reported findings from a follow-up Molecular Dynamics simulation study of the SARS-CoV-2 spike…
-
INEOS donated ﾣ100 million to create new Oxford University institute to fight antimicrobial resistance
On Jan. 19, 2021, a new state of the art institute for antimicrobial research iwasa announced at Oxford…
-
Pfizer and BioNTech published results of study showing COVID-19 vaccine antibodies neutralized UK strain
On Jan. 19, 2021, Pfizer and BioNTech announced that results from an in vitro study that provided additional…
-
TGen-NAU study results showed COVID-19 virus triggers antibodies from previous coronavirus infections
On Jan. 19, 2021, the Northern Arizona University and TGen, an affiliate of City of Hope, announced results…
-
Quest Diagnostics granted CDC contract to sequence COVID-19 gene variants to aid public health response
On Jan. 18, 2021, Quest Diagnostics announced that it has entered into an agreement with the Centers for…
-
Sequenced genome of the Australian lungfish 14x larger than human genome
On Jan. 18, 2021, researchers in Konstanz, Wurzburg, Hamburg and Vienna, led by evolutionary biologist Professor Axel Meyer…
-
Rapid blood test identified COVID-19 patients at high risk of severe disease
On Jan. 15, 2021, scientists at Washington University School of Medicine in St. Louis announced that that a…
-
Pfizer and BioNTech announced European scale-up of manufacturing capacities
On Jan. 15, 2021, Pfizer and BioNTech announced they had developed a plan that allowed the scale-up of…
-
RECOVERY trial closed recruitment to convalescent plasma treatment for patients hospitalised with COVID-19
On Jan. 15, 2021, Oxford University announced that on advice of the independent Data Monitoring Committee (DMC), recruitment…
-
NIAID microbiota study iIdentified nutrient that help prevent bacterial infection
On Jan. 15, 2021, scientists studying the bodyﾒs natural defenses against bacterial infection announced they had identified a…
-
UW researchers develop tool to equitably distribute limited vaccines
On Jan. 15, 2021, researchers at the University of Wisconsin School of Medicine and Public Health and UW…
-
VBI Vaccines announced publication of results from phase 4 study of prophylactic 3-ntigen HBV in vaccine
On Jan. 15, 2021, VBI Vaccines announced that results from a Phase 4 study of VBIﾒs prophylactic 3-antigen…
-
Innovation Pharma’s Brilacidin for the treatment of COVID-19 received FDA Fast Track Designation
On Jan. 14, 2021, Innovation Pharmaceuticals announced that the FDA had designated as a Fast Track development program…
-
Twist Bioscience began shipping of synthetic RNA controls for UK variant strain of SARS-CoV-2
On Jan. 14, 2021, Twist Bioscience announced that it had started shipping its new synthetic RNA reference controls,…
-
Cepheid received Health Canada license for SARS-CoV-2, Flu A, Flu B and RSV combination test
On Jan. 14, 2021, Cepheid that Health Canada announced that it had issued Cepheid a medical device license…
-
COVID-19 reduced US life expectancy, especially among Black and Latino populations
On Jan. 14, 2021, researchers from the University of Southern California and Princeton reported that the COVID-19 pandemic,…
-
PerkinElmer SARS-CoV-2 RT-PCR assay received FDA EUA for asymptomatic testing
On Jan. 14, 2021, PerkinElmer announced that its PerkinElmerﾮ Coronavirus Nucleic Acid Detection Kit received Emergency Use Authorization…
